Sentieon Inc.

San Jose, CA Doing business as Sentieon Inc.

UEI
GSJUN6H5PFN1
CAGE
81RV0
Primary NAICS
513210 Software Publishers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
Parking lot, 160 E Tasman Dr #208, San Jose, CA 95134, USA
Website
sentieon.com
Founded
2014
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Sentieon Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
The purpose of this requirement is to renew the annual sentieon license subscription for 1 year. Contract · 75N91026P00013 National Cancer Institute $20,000
Sentieon INC.:1307577 [24-038975] software publishers Contract · 75N91024P00709 National Cancer Institute $18,000
Sentieon INC.:1307577 [23-038950] a proprietary software for whole genome sequencing for never smokers study. Contract · 75N91023P00658 National Cancer Institute $12,000
Sentieon INC.:1307577 [22-055948] software license renewal Contract · 75N91022P00971 National Cancer Institute $12,000
Sentieon software Contract · 75F40121P00340 Food and Drug Administration $20,000

About Sentieon Inc.

Sentieon Inc., a self-certified small disadvantaged business based in San Jose, California, supplies proprietary bioinformatics and genomic data analysis software to federal research agencies as a prime contractor, operating exclusively in full-and-open competition with no set-aside designations across its federal footprint.

Sentieon specializes in software tools for processing and analyzing whole genome sequencing data, with a capability portfolio centered on DNAseq, DNAscope, TNseq, and TNscope bioinformatics pipelines. The company's recent federal work consists entirely of software license renewals and subscriptions supporting genomic research initiatives. Representative work includes a $20 thousand purchase order awarded by the National Cancer Institute on March 20, 2026, to renew an annual software license subscription through March 19, 2027; an $18 thousand purchase order from NCI awarded September 16, 2024, for bioinformatics software supporting whole genome sequencing; a $12 thousand NCI purchase order dated September 1, 2023, for proprietary software supporting the Never Smokers Study; and a $20 thousand Food and Drug Administration Total Small Business purchase order awarded September 15, 2021, for genomic research and analysis software. All awards are firm fixed-price purchase orders with no subcontractor involvement.

Customer concentration is heavily concentrated with the National Cancer Institute, which accounts for 7 of 9 awards and $101 thousand of the combined $133 thousand potential value (76% of the portfolio). The Food and Drug Administration and the NIH Clinical Center each hold one award. All customer agencies sit within the Department of Health and Human Services. The federal award footprint is classified as Software Publishers under NAICS, with perpetual-license and information-technology software delivery under PSC codes.

Activity over the past five years shows minimal volume — nine total awards across 2021 through 2026 — with sporadic annual placement (two awards in 2021, one each in 2022, 2023, and 2024, and one in 2026). One award reaches ultimate completion within the next twenty-four months, carrying $20 thousand in potential value and therefore exposing one license renewal to recompete. The vendor maintains no position on government-wide vehicles, BPAs, or agency IDIQs; all work flows through direct purchase orders issued by customer agencies.

Quick answers

What is Sentieon Inc.'s UEI?

Sentieon Inc.'s Unique Entity ID (UEI) in SAM.gov is GSJUN6H5PFN1.

What is Sentieon Inc.'s CAGE code?

Sentieon Inc.'s CAGE code is 81RV0.

What is Sentieon Inc.'s primary NAICS code?

Sentieon Inc.'s primary NAICS code is 513210 (Software Publishers).

Where is Sentieon Inc. located?

Sentieon Inc.'s physical address in SAM.gov is Parking lot, 160 E Tasman Dr #208, San Jose, CA 95134, USA.

Is Sentieon Inc. registered in SAM.gov?

Yes. Sentieon Inc.'s SAM.gov registration is active through February 18, 2027.

What is Sentieon Inc.'s most recent federal award?

Sentieon Inc.'s most recent federal contract award is The purpose of this requirement is to renew the annual sentieon license subscription for 1 year (75N91026P00013), from National Cancer Institute, on March 20, 2026.

On GovTribe

See Sentieon Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors